Literature DB >> 32624195

Sofosbuvir monotherapy fails to achieve HEV RNA elimination in patients with chronic hepatitis E - The HepNet SofE pilot study.

Markus Cornberg1, Sven Pischke2, Tobias Müller3, Patrick Behrendt4, Felix Piecha5, Julia Benckert3, Daniel Todt6, Eike Steinmann6, Armin Papkalla7, Maria von Karpowitz8, Armin Koch8, Ansgar Lohse2, Svenja Hardtke9, Michael P Manns10, Heiner Wedemeyer11.   

Abstract

Entities:  

Year:  2020        PMID： 32624195     DOI： 10.1016/j.jhep.2020.05.020

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  9 in total

Review 1.  Therapeutic Advances in Viral Hepatitis A-E.

Authors:  Navroop Nagra; Richard A Kozarek; Blaire E Burman
Journal:  Adv Ther       Date:  2022-02-27       Impact factor: 3.845

Review 2.  Sofosbuvir in the Treatment of Hepatitis E virus Infection: A Review of in vitro and in vivo Evidence.

Authors:  Temi Lampejo
Journal:  J Clin Exp Hepatol       Date:  2022-02-22

3.  Treatment for chronic hepatitis E virus infection: A systematic review and meta-analysis.

Authors:  Myrte Gorris; Bernice M van der Lecq; Karel J van Erpecum; Joep de Bruijne
Journal:  J Viral Hepat       Date:  2020-12-20       Impact factor: 3.728

Review 4.  Transfusion-transmitted hepatitis E: What we know so far?

Authors:  Carmen Ka Man Cheung; Sunny Hei Wong; Alvin Wing Hin Law; Man Fai Law
Journal:  World J Gastroenterol       Date:  2022-01-07       Impact factor: 5.742

Review 5.  Viral hepatitis in 2021: The challenges remaining and how we should tackle them.

Authors:  Rebecca Dunn; Aaron Wetten; Stuart McPherson; Mhairi C Donnelly
Journal:  World J Gastroenterol       Date:  2022-01-07       Impact factor: 5.742

6.  An RNA Interference/Adeno-Associated Virus Vector-Based Combinatorial Gene Therapy Approach Against Hepatitis E Virus.

Authors:  Viet Loan Dao Thi; Dirk Grimm; Cindy Zhang; Andrew Freistaedter; Carolin Schmelas; Manuel Gunkel
Journal:  Hepatol Commun       Date:  2021-10-31

7.  Different Kinetics of HBV-DNA and HBsAg in HCV Coinfected Patients during DAAs Therapy.

Authors:  Piero Colombatto; Elena Palmisano; Gabriele Ricco; Daniela Cavallone; Filippo Oliveri; Barbara Coco; Antonio Salvati; Veronica Romagnoli; Lidia Surace; Marialinda Vatteroni; Mauro Pistello; Agostino Virdis; Ferruccio Bonino; Maurizia Rossana Brunetto
Journal:  J Clin Med       Date:  2022-03-04       Impact factor: 4.241

Review 8.  Present and future management of viral hepatitis.

Authors:  Rocío González Grande; Inmaculada Santaella Leiva; Susana López Ortega; Miguel Jiménez Pérez
Journal:  World J Gastroenterol       Date:  2021-12-21       Impact factor: 5.742

9.  Viral Interference of Hepatitis C and E Virus Replication in Novel Experimental Co-Infection Systems.

Authors:  Thomas Burkard; Nora Proske; Kathrin Resner; Laura Collignon; Leonard Knegendorf; Martina Friesland; Lieven Verhoye; Ibrahim M Sayed; Yannick Brüggemann; Maximilian K Nocke; Patrick Behrendt; Heiner Wedemeyer; Philip Meuleman; Daniel Todt; Eike Steinmann
Journal:  Cells       Date:  2022-03-08       Impact factor: 6.600
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.